Reading LNSR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track LNSR free→Reading LNSR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track LNSR free→QuarterlyIQ Insights · LNSR
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 25, 2026, the Board of Directors (the “Board”) of LENSAR, Inc. (the “Company”) appointed Michael A. Rossi to serve as the Company’s Interim Chief Financial Officer and principal financial officer, effective as of May 29, 2026. Mr. Rossi, 52, previously served as Chief Financial Officer of Access Vascular, Inc., an early commercial stage medi…
Results of Operations and Financial Condition. On May 8, 2026, LENSAR, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter ended March 31, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchan…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 10, 2026, Thomas R. Staab, II, Chief Financial Officer of LENSAR, Inc. (the “Company”), notified the Company of his intention to resign from this position, effective May 8, 2026 (the “Transition Date”), to pursue other professional opportunities. Mr. Staab will continue serving as the Company’s principal financial officer through the Trans…
Results of Operations and Financial Condition. On March 31, 2026, LENSAR, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter and year ended December 31, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Se…
Regulation FD Disclosure. On March 16, 2026, the Company issued a press release announcing the termination of the Merger Agreement and the entry into the Termination Agreement. A copy of the press release is furnished herewith as Exhibit 99.1. The information included under this Item 7.01 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that sectio…
Termination of a Material Definitive Agreement. As previously disclosed, on March 23, 2025, LENSAR, Inc., a Delaware corporation (“LENSAR” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Alcon Research, LLC, a Delaware limited liability company (“Alcon”), and VMI Option Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Alcon (“Merger Sub” and, together with the Company and Alcon, the “Parties”), pursuant to which, and on th…
Entry into a Material Definitive Agreement. The disclosure set forth below under
Other Events. On March 12, 2026, LENSAR, Inc. (the “Company”) reported that it has entered into a Priority Credit Line Agreement, dated as of March 11, 2026 (the “PCL Agreement”), by and between the Company and Wells Fargo Bank, N.A (“Wells Fargo”). The PCL Agreement provides for a revolving, non-purpose margin credit facility, secured by a first-priority lien on a designated brokerage account maintained at Wells Fargo (the “Collateral Account”), of an amount based on the collateral value in…
Other Events. On March 12, 2026, LENSAR, Inc. (the “Company”) reported that it has entered into a Priority Credit Line Agreement, dated as of March 11, 2026 (the “PCL Agreement”), by and between the Company and Wells Fargo Bank, N.A (“Wells Fargo”). The PCL Agreement provides for a revolving, non-purpose margin credit facility of up to $50 million (subject to collateral value), secured by a first-priority lien on a designated brokerage account maintained at Wells Fargo (the “Collateral Accoun…
Results of Operations and Financial Condition. On November 4, 2025, LENSAR, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter ended September 30, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securiti…
Other Events. LENSAR, Inc. (the “Company”) announced today that the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”) has been scheduled for December 18, 2025 and is to be held virtually. All holders of record of common stock outstanding as of the close of business on October 24, 2025 will be entitled to vote at the 2025 Annual Meeting. The time and website address for the 2025 Annual Meeting will be set forth in the Company’s definitive proxy statement for the 2025 An…
Results of Operations and Financial Condition. On August 7, 2025, LENSAR, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter ended June 30, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exch…
Other Events As previously announced, on March 23, 2025, LENSAR, Inc. (“LENSAR”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Alcon Research, LLC, a Delaware limited liability company (“Parent” or “Alcon”), and VMI Option Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which, and on the terms and subject to the conditions thereof, Merger Sub will merge with and into LENSAR, with LENSAR surviving as a w…
Results of Operations and Financial Condition. On May 8, 2025, LENSAR, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter ended March 31, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchan…
Entry into a Material Definitive Agreement. Agreement and Plan of Merger On March 23, 2025, LENSAR, Inc., a Delaware corporation (“ LENSAR ” or the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Alcon Research, LLC, a Delaware limited liability company (“ Parent ” or “ Alcon ”), and VMI Option Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), pursuant to which, and on the terms and subject to the cond…
Results of Operations and Financial Condition. On February 27, 2025, LENSAR, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter and year ended December 31, 2024. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Company will host an earnings call on February 27, 2025, during which the Company will discuss its financial results for the fiscal quarter and…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.